These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2048219)

  • 101. Cholecystokinin A receptor (CCKAR) gene variation is associated with language lateralization.
    Ocklenburg S; Arning L; Gerding WM; Epplen JT; Güntürkün O; Beste C
    PLoS One; 2013; 8(1):e53643. PubMed ID: 23341962
    [TBL] [Abstract][Full Text] [Related]  

  • 102. New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges.
    Goldman JG
    Parkinsons Dis; 2011 Mar; 2011():675630. PubMed ID: 21403865
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.
    Hamamura M; Ozawa H; Ozaki M; Shimazoe T; Terada Y; Fukumaki Y
    J Neural Transm (Vienna); 2010 Sep; 117(9):1041-53. PubMed ID: 20680358
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.
    Copps J; Murphy RF; Lovas S
    Protein Pept Lett; 2009; 16(12):1504-18. PubMed ID: 20001914
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Altered orosensory sensitivity to oils in CCK-1 receptor deficient rats.
    Swartz TD; Hajnal A; Covasa M
    Physiol Behav; 2010 Jan; 99(1):109-17. PubMed ID: 19887078
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Dopamine D2 receptors contribute to increased avidity for sucrose in obese rats lacking CCK-1 receptors.
    Hajnal A; De Jonghe BC; Covasa M
    Neuroscience; 2007 Aug; 148(2):584-92. PubMed ID: 17681694
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.
    Anderzhanova E; Covasa M; Hajnal A
    Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R603-11. PubMed ID: 17553848
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Conditioned preference for sweet stimuli in OLETF rat: effects of food deprivation.
    De Jonghe BC; Hajnal A; Covasa M
    Am J Physiol Regul Integr Comp Physiol; 2007 May; 292(5):R1819-27. PubMed ID: 17272669
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Cholecystokinin hyperresponsiveness in functional dyspepsia.
    Chua AS; Keeling PW
    World J Gastroenterol; 2006 May; 12(17):2688-93. PubMed ID: 16718754
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Brief intermittent access to sucrose differentially modulates prepulse inhibition and acoustic startle response in obese CCK-1 receptor deficient rats.
    De Jonghe BC; Di Martino C; Hajnal A; Covasa M
    Brain Res; 2005 Aug; 1052(1):22-7. PubMed ID: 16002053
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.
    Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
    J Physiol; 2004 Feb; 555(Pt 1):71-84. PubMed ID: 14673185
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Neuropeptides involved in the pathophysiology of schizophrenia and major depression.
    De Wied D; Sigling HO
    Neurotox Res; 2002; 4(5-6):453-468. PubMed ID: 12754159
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.
    Pommier B; Beslot F; Simon A; Pophillat M; Matsui T; Dauge V; Roques BP; Noble F
    J Neurosci; 2002 Mar; 22(5):2005-11. PubMed ID: 11880531
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.
    Roques BP; Noble F
    Neurochem Res; 1996 Nov; 21(11):1397-410. PubMed ID: 8947930
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.
    Hernando F; Fuentes JA; Ruiz-Gayo M
    Br J Pharmacol; 1996 May; 118(2):400-6. PubMed ID: 8735644
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.
    Vasar E; Peuranen E; Harro J; Lang A; Oreland L; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):96-101. PubMed ID: 8397343
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
    Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
    Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Reversal of CRF- and dopamine-induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat.
    Gué M; Gleïzes-Escala C; Del Rio-Lacheze C; Junien JL; Buéno L
    Br J Pharmacol; 1994 Mar; 111(3):930-4. PubMed ID: 7912631
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse.
    Huppi K; Siwarski D; Pisegna JR; Wank S
    Genomics; 1995 Feb; 25(3):727-9. PubMed ID: 7759110
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.
    Lang A; Harro J; Soosaar A; Kõks S; Volke V; Oreland L; Bourin M; Vasar E; Bradwejn J; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):363-70. PubMed ID: 7630427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.